Literature DB >> 18385996

Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma.

Lale Kostakoglu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18385996     DOI： 10.1007/s00259-008-0787-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  54 in total

1.  COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma.

Authors:  D B Boyd; M Coleman; S W Papish; A Topilow; S K Kopel; B Bernhardt; J C Files; S Schwartz; M Gaynor; D McDermott
Journal:  J Clin Oncol       Date:  1988-03       Impact factor: 44.544

2.  A Gompertzian model of human breast cancer growth.

Authors:  L Norton
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

3.  Revised response criteria for malignant lymphoma.

Authors:  Bruce D Cheson; Beate Pfistner; Malik E Juweid; Randy D Gascoyne; Lena Specht; Sandra J Horning; Bertrand Coiffier; Richard I Fisher; Anton Hagenbeek; Emanuele Zucca; Steven T Rosen; Sigrid Stroobants; T Andrew Lister; Richard T Hoppe; Martin Dreyling; Kensei Tobinai; Julie M Vose; Joseph M Connors; Massimo Federico; Volker Diehl
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

4.  Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.

Authors:  Malik E Juweid; Gregory A Wiseman; Julie M Vose; Justine M Ritchie; Yusuf Menda; James E Wooldridge; Felix M Mottaghy; Eric M Rohren; Norbert M Blumstein; Alan Stolpen; Brian K Link; Sven N Reske; Michael M Graham; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2005-04-18       Impact factor: 44.544

5.  Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study.

Authors:  H C Kluin-Nelemans; V Zagonel; A Anastasopoulou; D Bron; K J Roozendaal; E M Noordijk; H Musson; I Teodorovic; B Maes; A Carbone; P Carde; J Thomas
Journal:  J Natl Cancer Inst       Date:  2001-01-03       Impact factor: 13.506

6.  A predictive model for aggressive non-Hodgkin's lymphoma.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

7.  Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.

Authors:  Jehan Dupuis; Philippe Gaulard; Francois Hemery; Emmanuel Itti; Christian Gisselbrecht; Alain Rahmouni; Christiane Copie-Bergman; Josette Brière; Taoufik El Gnaoui; Isabelle Gaillard; Michel Meignan; Corinne Haioun
Journal:  Haematologica       Date:  2007-06       Impact factor: 9.941

8.  Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results.

Authors:  G Bonadonna; M Zambetti; P Valagussa
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

9.  MACOP-B treatment for advanced stage diffuse large cell lymphoma: a multicenter Italian Study.

Authors:  U Vitolo; M Bertini; C Tarella; M C Bertoncelli; A Gallamini; E Gallo; A M Gatti; R Ghio; A Levis; G Luxi
Journal:  Eur J Cancer Clin Oncol       Date:  1989-10

10.  Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.

Authors:  K Spaepen; S Stroobants; P Dupont; P Vandenberghe; J Thomas; T de Groot; J Balzarini; C De Wolf-Peeters; L Mortelmans; G Verhoef
Journal:  Ann Oncol       Date:  2002-09       Impact factor: 32.976
View more
  2 in total

Review 1.  Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma.

Authors:  Andrea Gallamini
Journal:  Haematologica       Date:  2010-07       Impact factor: 9.941

2.  Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate.

Authors:  Gaetano Paone; Emmanuel Itti; Corinne Haioun; Philippe Gaulard; Jehan Dupuis; Chieh Lin; Michel Meignan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-19       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.